Determining diabetic retinopathy screening interval based on time from no retinopathy to laser therapy

Journal of Medical Screening

Volumn 24, Issue 4, 2017, Pages 170-175

  Hughes, Daniel ^a   Nair, Sunil ^b   Harvey, John N ^a  

^a BANGOR UNIVERSITY   (United Kingdom)

^b Countess of Chester Hospital ^*  (United Kingdom)

Author keywords

Diabetes; Diabetic retinopathy; Laser treatment; Visual outcome

Indexed keywords

ADULT; AGED; CLINICAL TRIAL; COHORT ANALYSIS; COMPLICATION; DIABETIC RETINOPATHY; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LOW LEVEL LASER THERAPY; MALE; MASS SCREENING; MIDDLE AGED; MULTICENTER STUDY; ORGANIZATION AND MANAGEMENT; TIME FACTOR; VISUAL DISORDER; WALES;

ADULT; AGED; COHORT STUDIES; DIABETIC RETINOPATHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LASER THERAPY; MALE; MASS SCREENING; MIDDLE AGED; TIME FACTORS; VISION DISORDERS; WALES;

EID: 85029171441     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1177/0969141316672687     Document Type: Article

References (21)

1. Evans J, Rooney C, Ashwood F, et al. Blindness and partial sight in England and Wales: April 1990-March 1991. Health Trends 1996; 28: 5-12.
2. Arun CS, Al-Bermani A, Stannard K, et al. Long-term impact of retinal screening on significant diabetes-related visual impairment in the working age population. Diabet Med 2009; 26: 489-492.
3. Liew G, Michaelides M and Bunce C. A comparison of the causes of blindness certifications in England and Wales in working age adults (16-64 years), 1999-2000 with 2009-2010. BMJ Open 2014; 2014: e004015.
4. Younis N, Broadbent DM, Harding SP, et al. Incidence of sight-threatening retinopathy in type 1 diabetes in a systematic screening programme. Diabet Med 2003; 20: 758-765.
5. Younis N, Broadbent DM, Vora JP, et al. Incidence of sight-threatening retinopathy in type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet 2003; 361: 195-200.
6. Soto-Pedre E, Hernaez-Ortega MC and Vazquez JA. Six-year retrospective follow-up study of safe screening intervals for sight-threatening retinopathy in patients with diabetes mellitus. J Diabetes Sci Technol 2009; 3: 812-818.
7. Agardh E and Tababat-Khani P. Adopting 3-year screening intervals for sight threatening retinal vascular lesions in type 2 diabetic subjects without retinopathy. Diabetes Care 2011; 34: 1318-1319.
8. Jones CD, Greenwood RH, Misra A, et al. Incidence and progression of diabetic retinopathy during 17 years of a population-based screening program in England. Diabetes Care 2012; 35: 592-596.
9. Thomas RL, Dunstan F, Luzio SD, et al. Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Screening Service for Wales: retrospective analysis. Br Med J 2012; 344: e874.
10. Looker HC, Nyangoma SO, Cromie DT, et al. Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme. Diabetologia 2013; 56: 1716-1725.
11. Porta M, Maurino M, Severini S, et al. Clinical characteristics influence screening intervals for diabetic retinopathy. Diabetologia 2013; 56: 2147-2152.
12. Leese GP, Stratton IM, Land M, et al. Progression of diabetes retinal status within community screening programs and potential implications for screening intervals. Diabetes Care 2015; 38: 488-494.
13. Harvey JN, Craney L, Nagendran S, et al. Towards comprehensive populationbased screening for diabetic retinopathy: operation of the North Wales diabetic retinopathy screening programme using a central patient register and various screening methods. J Med Screen 2006; 13: 87-92.
14. Thomas RL, Dunstan FD, Luzio SD, et al. Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service. Br J Ophthalmol 2015; 99: 64-68.
15. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs - an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology 1991; 98: 786-806.
16. Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Ophthalmology 1991; 98: 823-833.
17. Olafsdottir E and Stefansson E. Biennial eye screening in patients with diabetes without retinopathy: 10-year experience. Br J Ophthalmol 2007; 91: 1599-1601.
18. Kohner E, Stratton IM, Aldington SJ, et al. UK Prospective Diabetes Study (UKPDS) Group. Relationship between the severity of retinopathy and progression to photocoagulation in patients with type 2 diabetes mellitus in the UKPDS (UKPDS 52). Diabet Med 2001; 18: 178-184.
19. Kristinsson JK, Gudmundsson JR, Stefansson E, et al. Screening for diabetic retinopathy. Initiation and frequency. Acta Ophthalmol Scand 1995; 73:525-528.
20. Taylor-Phillips S, Mistry M, Leslie R, et al. Extending the diabetic retinopathy screening interval beyond 1 year: systematic review. Br J Ophthalmol. EPub ahead of print 13 January 2015. DOI: 10.1136/bjophthalmol-2014-305938.
21. Misra A, Bachmann MO, Greenwood RH, et al. Trends in yield and effects of screening intervals during 17 years of a large UK community-based diabetic retinopathy screening programme. Diabet Med 2009; 26: 1040-1047.